Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1976 1
1979 1
1980 3
1988 1
1990 3
1993 1
2000 3
2001 1
2003 1
2004 3
2005 3
2006 2
2008 4
2009 5
2010 5
2011 4
2012 2
2013 4
2014 1
2018 1
2019 1
2020 8
2021 6
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. Among authors: licata s. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
Gallbladder volvulus:  a case report.
Croce P, Licata S. Croce P, et al. Among authors: licata s. J Med Case Rep. 2021 Oct 9;15(1):494. doi: 10.1186/s13256-021-03115-7. J Med Case Rep. 2021. PMID: 34625099 Free PMC article.
Emergency Medical Services Calls During Italy's COVID-19 Lockdown.
Valent F, Licata S. Valent F, et al. Among authors: licata s. Ann Emerg Med. 2020 Dec;76(6):812-814. doi: 10.1016/j.annemergmed.2020.06.036. Epub 2020 Jun 22. Ann Emerg Med. 2020. PMID: 33222791 Free PMC article. No abstract available.
Social Work Training in Palliative Care: Addressing the Gap.
Thiel M, Mattison D, Goudie E, Licata S, Brewster J, Montagnini M. Thiel M, et al. Among authors: licata s. Am J Hosp Palliat Care. 2021 Aug;38(8):893-898. doi: 10.1177/1049909120960709. Epub 2020 Sep 24. Am J Hosp Palliat Care. 2021. PMID: 32969240
No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Spelman T, Trojano M, Wiendl H, Su R, Liao S, Hyde R, Licata S, Ho PR, Campbell N. Butzkueven H, et al. Among authors: licata s. Ther Adv Neurol Disord. 2021 Sep 27;14:17562864211042458. doi: 10.1177/17562864211042458. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34603507 Free PMC article.
57 results